Investor Day 2024
Logotype for Veeva Systems Inc

Veeva Systems (VEEV) Investor Day 2024 summary

Event summary combining transcript, slides, and related documents.

Logotype for Veeva Systems Inc

Investor Day 2024 summary

15 Jan, 2026

Strategic Vision and Long-term Goals

  • Announced a 2030 revenue goal of $6 billion, aiming to double revenue from 2025 to 2030, primarily through organic growth in life sciences and existing products.

  • Plans to expand into horizontal enterprise applications, targeting a $100B+ market opportunity, while building a next-generation application platform with a small, autonomous team.

  • Maintains core values of customer and employee success, product excellence, adaptability, and a strong company culture as a public benefit corporation.

  • Capital allocation prioritizes investment in new markets and organic growth, with flexibility for strategic acquisitions in new markets but not in core life sciences.

  • No material revenue contribution from new markets is expected by 2030; focus remains on execution in life sciences.

Product Strategy and Innovation

  • Multi-product operating model enables leadership across diverse product areas, with dedicated, lean teams for each product.

  • Vault Platform is central, supporting both R&D and commercial applications, and is being enhanced with innovations like Direct Data API and AI capabilities.

  • Migration from Veeva CRM to Vault CRM is progressing, with over 30 customers live and top 20 migrations expected to accelerate in 2025-2026.

  • Ongoing innovation includes new products in clinical and commercial clouds, with future launches planned.

  • AI strategy includes application-specific bots, direct data APIs, and a partner program to accelerate data-driven processes.

Market Opportunity and Customer Perspective

  • Life sciences industry TAM exceeds $20B, with penetration at ~14% and a 6%+ CAGR.

  • Industry is still early in digital transformation, with significant opportunity to improve automation and data integration.

  • Customers value quality, vision, and holistic platforms that break down silos, with large pharma and CROs as key segments.

  • Average products per customer continue to rise in both R&D and commercial segments.

  • External factors like elections and macroeconomic shifts have not materially impacted demand or customer investment cycles.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more